Rewiring ERBB3 and ERK signaling confers resistance to FGFR1 inhibition in gastrointestinal cancer harbored an ERBB3-E928G mutation
Sign Up to like & getrecommendations! Published in 2020 at "Protein & Cell"
DOI: 10.1007/s13238-020-00749-z
Abstract: Recently, a large number of studies found that activation of ERBB3 (Erb-B2 receptor tyrosine kinase 3, also known as HER3) may be one of the major mechanisms underlying resistance to therapies that target the EGFR… read more here.
Keywords: inhibitor; erbb3; resistance; erbb3 e928g ... See more keywords